93
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma

, , , &
Pages 1216-1218 | Received 06 Feb 2007, Accepted 15 Mar 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Beata Holkova, Victor Yazbeck, Maciej Kmieciak, Prithviraj Bose, Shuo Ma, Amy Kimball, Mary Beth Tombes, Ellen Shrader, Wen Wan, Caryn Weir-Wiggins, Amanda Singh, Kevin T. Hogan, Sarah Conine, Heidi Sankala, John D. Roberts, Thomas C. Shea & Steven Grant. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leukemia & Lymphoma 58:6, pages 1349-1357.
Read now

Articles from other publishers (6)

Junsheng Ye, Juan Li, Minjie Zhou, Renfei Xia, Rumin Liu & Lixin Yu. (2016) Modulation of Donor-Specific Antibody Production After Organ Transplantation by Valproic Acid. Transplantation 100:11, pages 2342-2351.
Crossref
Li Hua Dong, Shu Cheng, Zhong Zheng, Li Wang, Yang Shen, Zhi Xiang Shen, Sai Juan Chen & Wei Li Zhao. (2013) Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. Journal of Hematology & Oncology 6:1.
Crossref
Jasmine Zain. (2012) Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma. Hematology/Oncology Clinics of North America 26:3, pages 671-704.
Crossref
Fernando Cabanillas. (2011) Non-Hodgkin's Lymphoma: The Old and the New. Clinical Lymphoma Myeloma and Leukemia 11, pages S87-S90.
Crossref
Jasmine Zain & Owen A. O’Connor. (2010) Targeting histone deacetyalses in the treatment of B- and T-cell malignancies. Investigational New Drugs 28:S1, pages 58-78.
Crossref
Maribel Cotto, Fernando Cabanillas, Maribel Tirado, María V. García & Eileen Pacheco. (2010) Epigenetic therapy of lymphoma using histone deacetylase inhibitors. Clinical and Translational Oncology 12:6, pages 401-409.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.